Trends in incidence of small cell lung cancer and all lung cancer
- PMID: 21893364
- DOI: 10.1016/j.lungcan.2011.08.004
Trends in incidence of small cell lung cancer and all lung cancer
Abstract
Background: The incidence of small cell lung cancer (SCLC) is often quoted as 'around 20%' of all lung cancers but is reportedly decreasing over time. We analysed the trends in incidence of SCLC and compared these with the trends in lung cancer overall among males and females in South East England.
Methods: We identified 237,792 patients diagnosed with lung cancer (ICD-10 C33-C34) between 1970 and 2007. We used a Poisson regression age-cohort model to estimate the age-specific rates in the 1890-1960 birth cohorts. We computed age-standardised incidence rates using the European standard population. In addition, we analysed the trends of lung cancer subtypes according to morphology.
Results: In the most recent time period, SCLC accounted for 10% and 11% of cases of all lung cancer among males and females, respectively. Among the morphologically specified lung cancers, SCLC accounted for 15% and 17% among males and females, respectively. There was a decrease of SCLC incidence over time and by birth cohort in both sexes. The decrease in SCLC was more marked than that in all lung cancers.
Conclusion: The decrease in SCLC incidence rates may reflect decreases in the prevalence of cigarette smoking, and changes in the type of cigarettes smoked.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Trends in lung cancer incidence by histologic subtype in the south of Spain, 1985-2012: a population-based study.Clin Transl Oncol. 2016 May;18(5):489-96. doi: 10.1007/s12094-015-1392-x. Epub 2015 Sep 2. Clin Transl Oncol. 2016. PMID: 26329296
-
31 years of lung cancer in the canton of Zurich, Switzerland: incidence trends by sex, histology and laterality.Swiss Med Wkly. 2016 Jul 11;146:w14327. doi: 10.4414/smw.2016.14327. eCollection 2016. Swiss Med Wkly. 2016. PMID: 27400130
-
Time trend and the age-period-cohort effect on the incidence of histologic types of lung cancer in Connecticut, 1960-1989.Cancer. 1994 Sep 1;74(5):1556-67. doi: 10.1002/1097-0142(19940901)74:5<1556::aid-cncr2820740511>3.0.co;2-0. Cancer. 1994. PMID: 8062189
-
[Epidemiology of malignant tumors of the larynx and lung].Ann Ist Super Sanita. 1992;28(1):107-20. Ann Ist Super Sanita. 1992. PMID: 1497240 Review. Italian.
-
SCLC: Epidemiology, Risk Factors, Genetic Susceptibility, Molecular Pathology, Screening, and Early Detection.J Thorac Oncol. 2023 Jan;18(1):31-46. doi: 10.1016/j.jtho.2022.10.002. Epub 2022 Oct 12. J Thorac Oncol. 2023. PMID: 36243387 Free PMC article. Review.
Cited by
-
MCF2L-AS1/miR-874-3p/STAT3 feedback loop contributes to lung adenocarcinoma cell growth and cisplatin resistance.Heliyon. 2023 Oct 29;9(11):e21342. doi: 10.1016/j.heliyon.2023.e21342. eCollection 2023 Nov. Heliyon. 2023. PMID: 37954302 Free PMC article.
-
Pulmonary Nodule Detection Model Based on SVM and CT Image Feature-Level Fusion with Rough Sets.Biomed Res Int. 2016;2016:8052436. doi: 10.1155/2016/8052436. Epub 2016 Sep 18. Biomed Res Int. 2016. PMID: 27722173 Free PMC article.
-
Feasibility and validity of The Health Improvement Network database of primary care electronic health records to identify and characterise patients with small cell lung cancer in the United Kingdom.BMC Cancer. 2019 Jan 21;19(1):91. doi: 10.1186/s12885-019-5305-1. BMC Cancer. 2019. PMID: 30665371 Free PMC article.
-
RYBP Inhibits Progression and Metastasis of Lung Cancer by Suppressing EGFR Signaling and Epithelial-Mesenchymal Transition.Transl Oncol. 2017 Apr;10(2):280-287. doi: 10.1016/j.tranon.2017.01.004. Epub 2017 Feb 28. Transl Oncol. 2017. PMID: 28254703 Free PMC article.
-
Epigenetics of Most Aggressive Solid Tumors: Pathways, Targets and Treatments.Cancers (Basel). 2021 Jun 27;13(13):3209. doi: 10.3390/cancers13133209. Cancers (Basel). 2021. PMID: 34198989 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
